Back to search results

Understanding Preferences for Geriatric and Functional Assessments in Cancer Treatment

This study aims to understand how sharing information about your health and physical abilities (geriatric and objective functional assessments) affects treatment decisions for older adults with cancer. It will look at whether receiving these detailed assessments helps you better understand your condition and make informed choices about your care. The main goal is to see if this information changes your treatment priorities, helping you focus on what matters most to you. You may be eligible if you are 65 or older and have recently started or are considering a new cancer treatment regimen. The study plans to enroll 100 participants. Success will be measured by changes in your preferences for quality versus quantity of life after receiving your assessment results.

Study design
This is a randomized study involving 100 participants. You would be randomly assigned to either receive your assessment results early or later.
What's involved
You will complete questionnaires at the beginning of the study and again about four weeks later. You will also undergo geriatric and objective functional assessments.
Compensation
Not stated in the trial record.
Follow-up
Your preferences will be assessed from the start of the study until about four weeks after enrollment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06652347

Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.

Recruiting
NAAges 65+InterventionalSupportive care
Fox Chase Cancer Center
~100 participants
Updated 2025-02-27 on ClinicalTrials.gov
What's tested:Cancer care delivery

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Absolute change in QQ-Length of life from baseline to post-intervention
Measured over From baseline questionnaire at enrollment to post intervention questionnaire at an average of 4 weeks after enrollment.

Conditions

Care Delivery
Geriatrics
Geriatric Assessment

Explore related trials

Malignant Neoplasm

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Zachary Frosch, MD, MSHP · PRINCIPAL_INVESTIGATOR · Fox Chase Cancer Center

Who to contact

Zachary Frosch, MD MSHP
[email protected]
215-728-2674
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 65
Started a new qualifying index regimen within the last 30 days (inclusive)
Are being considered for a new qualifying index regimen

Exclusion

Patients will be excluded if they
Do not have the capacity to consent to study procedures
Are unable to complete English language questionnaires
Are already using an activity tracker on a daily basis (and therefore may be aware of their current level of activity)

What this trial measures

  • Absolute change in QQ-Length of life from baseline to post-interventionFrom baseline questionnaire at enrollment to post intervention questionnaire at an average of 4 weeks after enrollment.

    The QQ uses a 5-point Likert scale to rate each of the 4 questions on the QQ-L subscale. The scores for this subscale are then summed, meaning that patients will receive a score ranging from 4-20 for the QQ-L. The total score from the 4 QQ-L items measures the strength of a participant's preference for length of life, with higher scores meaning greater preference for length of life.